A detailed history of Blb&B Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Blb&B Advisors, LLC holds 50,862 shares of MRK stock, worth $5.24 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
50,862
Previous 50,538 0.64%
Holding current value
$5.24 Million
Previous $6.26 Million 7.69%
% of portfolio
0.3%
Previous 0.34%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$111.15 - $128.97 $36,012 - $41,786
324 Added 0.64%
50,862 $5.78 Million
Q2 2024

Jul 26, 2024

BUY
$123.8 - $132.96 $57,071 - $61,294
461 Added 0.92%
50,538 $6.26 Million
Q1 2024

Apr 26, 2024

SELL
$113.24 - $131.95 $157,743 - $183,806
-1,393 Reduced 2.71%
50,077 $6.61 Million
Q4 2023

Jan 19, 2024

SELL
$100.18 - $109.02 $82,748 - $90,050
-826 Reduced 1.58%
51,470 $5.61 Million
Q3 2023

Oct 24, 2023

SELL
$102.95 - $114.33 $138,261 - $153,545
-1,343 Reduced 2.5%
52,296 $5.38 Million
Q2 2023

Jul 20, 2023

SELL
$108.61 - $118.38 $231,339 - $252,149
-2,130 Reduced 3.82%
53,639 $6.19 Million
Q1 2023

Apr 21, 2023

SELL
$102.94 - $114.86 $185,189 - $206,633
-1,799 Reduced 3.13%
55,769 $5.93 Million
Q4 2022

Jan 17, 2023

SELL
$87.44 - $112.11 $346,699 - $444,516
-3,965 Reduced 6.44%
57,568 $0
Q3 2022

Oct 14, 2022

SELL
$84.53 - $94.96 $26,119 - $29,342
-309 Reduced 0.5%
61,533 $5.3 Million
Q2 2022

Jul 18, 2022

SELL
$83.49 - $94.64 $332,707 - $377,140
-3,985 Reduced 6.05%
61,842 $5.64 Million
Q1 2022

Apr 20, 2022

SELL
$73.51 - $82.4 $198,477 - $222,480
-2,700 Reduced 3.94%
65,827 $5.4 Million
Q4 2021

Jan 21, 2022

SELL
$72.28 - $90.54 $2.05 Million - $2.56 Million
-28,304 Reduced 29.23%
68,527 $5.25 Million
Q3 2021

Oct 19, 2021

BUY
$71.68 - $78.83 $1.67 Million - $1.83 Million
23,240 Added 31.58%
96,831 $7.27 Million
Q2 2021

Jul 20, 2021

SELL
$70.31 - $77.77 $112,636 - $124,587
-1,602 Reduced 2.13%
73,591 $5.72 Million
Q1 2021

Apr 19, 2021

SELL
$68.86 - $81.11 $2.28 Million - $2.68 Million
-33,080 Reduced 30.55%
75,193 $5.8 Million
Q4 2020

Jan 19, 2021

BUY
$71.77 - $79.65 $1.05 Million - $1.17 Million
14,642 Added 15.64%
108,273 $8.86 Million
Q3 2020

Oct 20, 2020

SELL
$73.18 - $82.95 $132,382 - $150,056
-1,809 Reduced 1.9%
93,631 $7.77 Million
Q2 2020

Jul 16, 2020

SELL
$70.42 - $80.13 $149,783 - $170,436
-2,127 Reduced 2.18%
95,440 $7.38 Million
Q1 2020

Apr 21, 2020

SELL
$63.36 - $87.82 $184,821 - $256,170
-2,917 Reduced 2.9%
97,567 $7.51 Million
Q4 2019

Jan 21, 2020

SELL
$77.58 - $87.54 $226,688 - $255,791
-2,922 Reduced 2.83%
100,484 $9.14 Million
Q3 2019

Oct 22, 2019

SELL
$76.08 - $82.93 $66,874 - $72,895
-879 Reduced 0.84%
103,406 $8.71 Million
Q2 2019

Jul 29, 2019

SELL
$69.84 - $81.59 $200,231 - $233,918
-2,867 Reduced 2.68%
104,285 $8.74 Million
Q1 2019

Apr 19, 2019

SELL
$69.58 - $79.36 $158,294 - $180,544
-2,275 Reduced 2.08%
107,152 $8.91 Million
Q4 2018

Jan 17, 2019

SELL
$65.24 - $75.71 $128,653 - $149,300
-1,972 Reduced 1.77%
109,427 $8.36 Million
Q3 2018

Oct 12, 2018

SELL
$57.69 - $67.84 $376,715 - $442,995
-6,530 Reduced 5.54%
111,399 $7.9 Million
Q2 2018

Jul 11, 2018

SELL
$50.83 - $59.72 $58,352 - $68,558
-1,148 Reduced 0.96%
117,929 $7.16 Million
Q1 2018

Apr 09, 2018

BUY
$50.96 - $59.23 $91,575 - $106,436
1,797 Added 1.53%
119,077 $6.49 Million
Q4 2017

Jan 16, 2018

BUY
$51.62 - $61.64 $172,049 - $205,446
3,333 Added 2.93%
117,280 $6.6 Million
Q3 2017

Oct 16, 2017

BUY
$58.67 - $63.13 $6.69 Million - $7.19 Million
113,947
113,947 $7.3 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Blb&B Advisors, LLC Portfolio

Follow Blb&B Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.